Introduction
Pneumocystis carinii is an opportunistic pathogen which often causes fatal pneumonia in patients under immunosuppressed or immune deficient conditions due to AIDS, cancer chemotherapy or immunosuppressive therapy for organ transplantation 1). Although P, carinii was first described by Chagas in 19092), it was not until the 1980's that people became seriously aware of P. carinii when it emerged as a leading cause of opportunistic pulmonary infection and mortality in AIDS patients. The clinical importance of the organism was accentuated by the fact that anti-P. carinii agents exhibited major problems of efficacy and toxicity. Solutions to these problems, however, were not easily found because basic research on P, carinii had so far been ignored. Nevertheless, in recent years since investigators succeeded in isolating nucleic acids from this organism in 19883,4), there have been marked advances in the molecular biology of P, carinii, which led to a new stage of pathobiological and clinical studies5,6).
Life Cycle P. carinii is a eukaryotic microorganism that can infect many mammalian hosts, including mice, rats, guinea pigs, rabbits, ferrets, dogs, and horses. The difficulty of continuous in vitro cultivation of P. carinii impeded the progress of the fundamental study of this organism. Therefore, most of our knowledge has emerged from ultrastructural studies of infected rodents or humans7). P. carinii develops naturally in alveoli, and has two predominant forms in the life cycle: one, a vegetative form, i.e, a small unicellular 'tr ophozoite'; and the other, a resting form, i.e. 'cyst' containing eight intracystic bodies. Cysts are assumed to give rise to daughter trophozoites8).
Trophozoites are most likely responsible for the infection although there is no evidence of which form is infectioe. According to the textbook view, inhalation of airborne organisms in early childhood exposes humans to P. carinii. It has been widely believed that the organism evades clearance and remains quiescent in the host for long periods of time despite intact immunity. Under conditions of immune deficiency or suppression, a latent infection is reactivated. On the other hand, evidence of miniepidemics of P. carinii pneumonia has recently raised the concern that P, carinii pneumonia is due to reinfection rather than relapse since the infection may be transferable from one immunosuppressed patient to another9). Animal studies of P. carinii pneumonia have documented animal-toanimal transfer and seem to support this finding5). Current application of PCR to diagnosis indicated that P. carinii disappears during the course of therapeutic treatment with anti-P, carinii drugs and is not detected in normal lungs or sputum 10, 11), Using animal models, it remains to be investigated whether P, carinii pneumonia is due to relapse or reinfection, though they may not be mutually exclusive.
Molecular Taxonomy
P. carinii was found more than 80 years ago and was traditionally thought to be a protozoan. This misconception was perpetuated by its response to anti-protozoan agents such as pentamidine and trimethaprim/sulfamethoxazole.
However, a number of P. carinii genes have been cloned and sequenced, facilitating molecular taxonomy. Ribosomal RNA genes have been widely used to study the evolutionary relationships among microorganisms 12). Analysis of the 5 S RNA or 18S RNA for rat P. carinii revealed that the organism is much more closely related taxonomically to fungi such as Saccharomyces cerevisiae or Shizosaccharomyces pombe than to protozoa4,13,14). Analysis of other ribosomal RNA genes (5.8S, 26S) supported the close relationship to fungi 15, 16). This was further confirmed by the presence of the translation elongation factor 3 gene, which is specific to fungi, in P. carinii organisms 17).
Although increasing evidence supports the close relationship to fungi, it is unknown to what degree this molecular taxonomy reflects the true nature of P. carinii. As described below, P. carinii has a genetic system to switch cell surface antigens, which is known for the protozoan Trypanosoma, but not for fungi. Several criteria may be required for determining the taxonomic status of P, carinii.
Molecular Biology
There have been striking advances in P. carinii research in recent years in the area of molecular biology and the related pathobiology 5,18). As described above, several P. carinii genes encoding proteins, enzymes and rRNAs were cloned and sequenced. For taxonomic analysis as well as for the discovery of anti-P. carinii drugs, several metabolic enzyme genes were cloned, including those for dihydrofolate reductase (DHFR) and thymidylate synthase (TS) that are encoded on separate chromosomes 19,20). Studies of the base composition of the genome of rat P. carinii have shown a high content of adenine (A) and thymine (T) 19-23), These studies not only significantly improved our basic understanding of P. carinii, but provided us with powerful technology for clinical application as will be described shortly.
The genome of P. carinii has been studied by electrophoretic karyotyping, i.e., the separation of chromosomes by pulse field radiant gel electrophoresis. This study showed that the haploid genome consists of about 13-16 chromosomes containing 700-1000 kb of DNA, which is approximately two-thirds the size of the Saccharomyces genome24-26). Differences in the karyotype pattern have appeared in P. carinii isolates from different rat strains and different commercial vendors 2628) The diversity of the karyotype pattern was also seen among human P, carinii isolates, which seem to consist of equivalent numbers of karyotype bands between 200 and 700 kb in size, as well as among P. carinii isolates from other animals29), showing the heterogeneity of P. carinii isolates. Another work has also indicated that some laboratory rats can contain two different genetic variants of P, carinii that differ in electrophoretic karyotype28).
Molecular Diagnosis
A definitive diagnosis of P. carinii pneumonia can only be made by detecting the organism in clinical specimens, such as sputum, bronchoalveolar lavage fluid and transbronchial biopsy samples. Conventionally, Grocott, toluidine blue O, and Giemsa stainings are usually performed to identify P. carinii in these materials. These histochemical methods, however, have an inherent lack of sensitivity and/or specificity and the organism can not always be detected, especially in non-invasive specimens. Therefore, due to the uncertainty of the diagnosis, a number of patients are treated with anti-P. carinii therapy coincident with ganciclovir and/or other antibiotic therapy. In contrast to the uncertainty of standard diagnosis methods, the polymerase chain reaction (PCR) method provides better sensitivity and specificity in detecting P. carinii10,11,30). There have been increasing applications of PCR to detect P. carinii genes including ribosomal DNAs in the respiratory tract of patients and animal models with pneumocystosis 31-36), Improved diagnoses by PCR have indeed made bronchoscopy unnecessary in many cases. P. carinii pneumonia in patients with AIDS is usually treated for 3 weeks and those with other types of immunodeficiency for 2 weeks, both determined empirically. In other words, therapy is continued based on the regimen but not on a valid index of morbidity, because there have been no reliable therapeutic markers. Nevertheless, PCR allows early diagnosis of P, carinii pneumonia and close therapeutic monitoring with non-invasive specimens such as sputum37).
Surface Antigens and Pathobiology P. carinii are coated by abundant surface proteins of great interest to investigators21,22,38-59) The major protein components of both cysts and trophozoites are proteins called MSG (for major surface glycoprotein)5,58,59), p11546), gp 12048) or gpA 56,57), with an apparent molecular mass ranging from 95 to 140 kDa, depending on host species, degree of glycosylation, and isolation procedures. The nomenclature for this antigen complex is somewhat confusing, and we refer to it here as MSG as it represents closely the nature of this antigen.
Upon P. carinii infection, the organism passed through the initial host defenses is deposited within alveoli. The initial event in the pathogenesis of P. carinii pneumonia is the preferential attachment of the organism to type I alveolar epithelial cells18). Although the mechanisms of attachment are not fully understood, MSG is thought to play an important role in the interaction of P. carinii with host cells, involving other components such as cell adhesive proteins and lectins44,60-68). P. carinii trophozoites can bind to alveolar epithelial cells by using fibronectin as a ligand, and MSG has been implicated as the binding site for fibronectin.
Other extracellular matrix adhesive proteins that may be involved include laminin and vitronectin.
P. carinii may also bind to epithelial cell surface glycoproteins by means of a mannose-dependent mechanism69). Thus, attachment to type-I alveolar epithelial cells may be mediated by multiple mechanisms.
There is evidence that P. carinii infection stimulates humoral and cellular immune responses in the host. For example, passive immunization with an anti-MSG monoclonal antibody partially protects against the progression of P. carinii pneumoma in animal models70), and a specific T-cell response to MSG molecules occurs after immunization and natural infection71,72). Hyperimmune serum administered to SLID mice with P. carinii pneumonia results in clearing of the infection73). Cases of pneumocystosis have also been described in patients and mice with B-cell defects 74-76)
The alveolar macrophages play a central role in the clearance of microorganisms from the lung through migration, attachment and phagocytosis. Binding of P, carinii to macrophages is mediated by adhesive proteins such as fibronectin77) and by mannose-dependent mechanisms in which the macrophage mannose receptor clearly targets the mannose moiety of MSG for uptake78). Clearly, MSGs play a crucial role in pathobiology of P. carinii such as infection, host-parasite interaction and host defense.
Major Surface Glycoprotein
The frequent generation of anti-MSG monoclonal antibodies implicated the strong antigenic activity of MSG molecules, presumably, in part, because of their unusual abundance on the surface of P. carinii. Immunohistochemical analysis using anti-MSG monoclonal antibodies demonstrated that ferritin granules conjugated with these antibodies bound to the surface of the cyst as well as of the trophozoite of P, carinii46). Immunoblotting analysis of P. carinii proteins separated by SDSpolyacrylamide gel electrophoresis clearly showed that a major part of the total protein is seen in both cysts and trophozoites at 105-120 kDa and that this major broad band is a common epitope to the anti-MSG monoclonal antibody46, 48) The P. carinii cyst has a thick cell wall composed of carbohydrates, consisting primarily of glucose, mannose, galactose, and lesser amounts of N-acetyl-D-glucosamine, ribose, and sialic acid 79). MSG contains mannosyl, glycosyl, and Nacetylglucosamine residues, displays species-specific antigenic variation, and possesses collagenase sensitivity. Tanabe et al. 46 ) first demonstrated biochemically that MSGs are glycoproteins containing mannose-rich oligosaccharides.
They analyzed the monosaccharide composition of MSG by high-performance liquid chromatography after hydrolysis to monosaccharides, revealing that mannose is the main sugar component. Mammalian alveolar macrophages express a receptor that binds mannosylated glycoproteins80-82), and the mannose moiety of MSGs is attacked by the macrophage in the uptake of P. carinii78).
Biochemical studies have revealed that MSGs are acidic glycoproteins that have several isoelectric points45,46) Deglycosylation with endoglycosidase F or a-mannosidase increased migration of MSG molecules in SDS polyacrylamide gel electrophoresis, and decreased isoelectric variation46). Most monoclonal and polyclonal antibodies reacted with all of these isoelectric variants. However, these deglycosylated MSGs no longer, if at all, reacted with most antibodies against authentic MSGs, showing that the sugar moiety participates in the strong immunodeterminant structure of P. carinii. Limiting proteolysis of the isoelectric variants generated common major fragments, showing that they share a common polypeptide portion. Isoelectric variation, therefore, seems to be caused mainly by heterogeneity in the carbohydrate chains.
MSG cDNAs
MSG genes are highly polymorphic, preventing us from viewing them simplistically. After some years of investigation, three groups have succeeded in the cloning of MSG cDNAs. Haidaris et al.57) have reported the partial cloning and sequence of a cDNA encoding a gpA antigen, analogous to MSG, of P. carinii from ferrets. Kovacs et al.58) and Wada et al.59) have reported the cloning and sequence of a cDNA encoding MSG of P. carinii from rats. Screening of the cDNA expression library of P. carinii using anti-MSG antibody has shown that the frequency of appearance of positive clones was unusually high (10-2-10-3) reflecting the abundance of MSG in the vegetative cycle of P, carinii. These cDNA clones encoded a single open reading frame, shared identical or homologous sequences, and were classified to different subtypes.
Through these cDNA analyses, it became apparent that the MSG subtypes of rat P. carinii are homologous over the entire length of the proteins except for some variable regions. The variable regions map to the middle of the proteins as well as to the C-terminal region83) except for the C-terminal end which is highly conserved 84). The MSG family of rat P . carinii contains 65-80% identical amino acids among the subtypes and shares 32-36% identical amino acids with gpA of ferret-derived P. carinii.
The 5' upstream regions of MSG-cDNAs were investigated by the 5' RACE method85). The data revealed that 5' RACE products contained a highly conserved sequence in their 5' region (termed UCS for upstream conserved sequence). Northern blot hybridization showed that the UCS was present in the majority of the MSG transcripts. Sequence analysis of UCS-MSG transcripts showed them all to contain the same UCS85). MSG mRNAs initiate at one of two sites, P1 or P2. All the clones were identical in sequence from P2. Sequence analysis of these RACE clones revealed a translation start site, and initiation from this AUG would produce a putative signal peptide which may be used in deposition of MSGs on the cell surface.
Genomic
Organization for MSG Genomic hybridization analysis clearly indicated that the cDNA diversity reflects a multiple MSG-gene family in the P. carinii chromosome. An MSG cDNA probe hybridized to multiple restriction fragments, while the same probes did not hybridize to DNAs from uninfected rat lungs. Therefore, a complex group of MSG genes indeed exists in P. carinii. Moreover, PCR analysis demonstrated that at least some MSG genes cluster tandem in the chromosome59).
In fact, several genomic fragments carrying two or three MSG genes have been cloned86-89). Therefore, sequence diversity of MSG-cDNAs is likely caused by the diversity as well as the multiplicity of genomic MSG genes.
Each P. carinii cell has the potential to express a number of different MSG isoforms because the genome of P. carinii encodes at least a hundred different MSG genes, distributed among all of the 14-15 discernible chromosomes58,59,89). The multiplicity and diversity of MSG genes were first discovered in P. carinii from rats. Cloning and sequencing analyses using organisms from other animals such as ferrets, mice, and humans, have subsequently shown a similar sequence diversity and multiplicity of MSG29, 86, 90), The precise degree of multiplicity remains to be investigated. Comparison of RACE clones to genomic clones 87-89) showed that they diverge just upstream of position 400. Southern blot hybridization clarified the reason for this. The UCS probe hybridized to a single band (approximately 500 kb in size) in the electrophoretic karyotype, while an MSG probe hybridized to all the bands. Similarly, the UCS hybridized to relatively few restriction fragments of P. carinii DNA, as compared to an MSG probe. These experiments suggest that the UCS is located on one chromosome, in which case most MSG genes cannot be linked to the UCS. Those MSG genes that were attached to a UCS were amplified by the PCR using an upstream sense primer of UCS, paired with a downstream antisense primer of the variable portion of MSG. The amplified products contained a mixture of DNA fragments that shared a UCS at one end, and contained a different MSG gene at the other 85, 91) . Some of these clones chosen at random were all different in the MSG region, suggesting that the population of P. carinii genomes contained many different MSG genes attached to the UCS. Although the sequence of UCS is highly conserved, extensive amplification of UCS sequences from rat P. carinii populations showed some slight polymorphism within the UCS sequence91)
These results show that the most abundant MSG mRNAs are attached to UCS, a sequence that is found on only one of the P. carinii chromosomes resolved by electrophoresis. The UCS is found attached to MSG genes, suggesting that the UCS occupies a genome position permissive for MSG transcription. The most likely explanation is that the population is genetically heterogeneous at the UCS locus, and that this heterogeneity is brought about by DNA recombination, which installs different MSG coding sequences at a limited number of expression sites (perhaps only one) as will be discussed shortly. Initial hybridization data have shown that the UCS was present on only one band in an electrophoretic karyotype, suggesting that the UCS locus is unique85).
Telomeric Localization and Expression of MSG
Several lines of evidence showed that a UCS site. is telomeric91,92). A telomeric UCS DNA was cloned from a genomic library of P. carinii, and telomeric 11-kb UCS fragments were identified92) Sequence analysis of one of the clones, A MW 124, showed that it contained the UCS and one MSGcoding sequence, but no other significant open reading frames. This MSG sequence is highly homologous, but not identical, to the known MSG genes. At the 3' terminus, there were seven tandem hexanucleotide repeats with the sequence of TTAGGG oriented 5' to 3' to the chromosomal end. TTAGGG is the sequence of telomeric DNA in all vertebrates, the protozoan Trypanosoma, and several slime molds and fungi, revealing that the UCS is telomeric. The subtelomeric regions immediately internal to the simple repeats consist of moderately repetitive sequences, called telomereassociated DNA.
The TTAGGG telomere sequence and subtelomeric sequences are not unique to the 0.5 megabase chromosome containing UCS, but seem to be common to all other P. carinii chromosomes. The 14-15 chromosome blot resolved by pulse-field gel electrophoresis hybridized to this hexamer sequence as well as to the subtelomeric sequences92). Telomeric fragments other than the UCS were cloned by screening with the (TTAGGG)5-oligo DNA probe and the subtelomeric probe. Until now, two non-UCS telomeric clones were sequenced and shown to contain TTAGGG repeats at the termini as well as subtelomeric repetitive regions common to the UCS-MSG expression site. Moreover, these two clones contained MSG gene(s) being not associated with the UCS. Frequent occurrences of these telomeric MSG clones (3X10-4) indicate that they represent silent MSG genes localized in the telomere regions.
The discovery of a UCS expression site within the telomere region suggests that MSG genes or batteries of them are translocated to the UCS expression site by means of reciprocal recombination or gene conversion. This seems to be true of the DNA rearrangement of the Variant Surface Glycoprotein (VSG) genes of the protozoan parasite Trypanosoma brucei93-95). Trypanosome VSG undergoes antigenic variation to evade the host immune system. There are many VSG genes on the chromosomes and minichromosomes, but the VSG expression sites are restricted to telomeric regions and silent VSG genes can be translocated to the expression site by DNA recombination93-95). The same telomere-associated recombination model for P. carinii MSGs has been proposed91,96). 
